BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1695795)

  • 1. Editorial: Interferons: key modulators of the immune system in cancer.
    Yusuf N; Allie SR; Strauss BE
    Front Immunol; 2023; 14():1327311. PubMed ID: 38022597
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferons as Therapy for Viral and Neoplastic Diseases: From Panacea to Pariah to Paragon.
    Friedman RM; Contente S
    Pharmaceuticals (Basel); 2009 Dec; 2(3):206-216. PubMed ID: 27713234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-alpha 2b inhibits proliferation of human Tenon's capsule fibroblasts.
    Gillies M; Su T; Sarossy M; Hollows F
    Graefes Arch Clin Exp Ophthalmol; 1993 Feb; 231(2):118-21. PubMed ID: 8444359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulators. Future prospects.
    Takx-Köhlen BC
    Pharm Weekbl Sci; 1992 Aug; 14(4A):245-52. PubMed ID: 1437506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer immunotherapy: the interferon-alpha experience.
    Kirkwood J
    Semin Oncol; 2002 Jun; 29(3 Suppl 7):18-26. PubMed ID: 12068384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotherapy in clinical practice.
    Figlin RA
    Semin Hematol; 1989 Jul; 26(3 Suppl 3):15-24. PubMed ID: 2477904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotherapy with interferon--1988.
    Figlin RA
    Semin Oncol; 1988 Dec; 15(6 Suppl 6):3-9. PubMed ID: 2462749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of biologic response modifiers in cancer treatment: an overview. Part I. The interferons.
    Balmer CM
    DICP; 1990; 24(7-8):761-8. PubMed ID: 1695795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of interferons in the treatment of cancer.
    Hansen RM; Borden EC
    Oncology (Williston Park); 1992 Nov; 6(11):19-24; discussion 26, 29. PubMed ID: 1280153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic response modifiers: the interferon alfa experience.
    Koeller JM
    Am J Hosp Pharm; 1989 Nov; 46(11 Suppl 2):S11-5. PubMed ID: 2481396
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.